Xue Yang

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Endometrial Cancer

Top Venues

International journal of molecular sciences

NPJ precision oncology

Future oncology (London, England)

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Khaled Mohamed Nassar, Xue Yang, Adriana Baker, Rahul Gopalam, William C Arnold, Timilehin T Adeniran, Marian H Hernandez Fernandez, Megharani Mahajan, Zhao Lai, Yidong Chen, Gangadhara R Sareddy, Suryavathi Viswanadhapalli, Lu-Zhe Sun, Ratna K Vadlamudi, Uday P Pratap
PELP1 is a novel therapeutic target in hepatocellular carcinoma. Cancer research communications (2024)
Behnam Ebrahimi, Suryavathi Viswanadhapalli, Uday P Pratap, Gopalam Rahul, Xue Yang, Prabhakar Pitta Venkata, Viktor Drel, Bindu Santhamma, Swapna Konda, Xiaonan Li, Alondra Lee Rodriguez Sanchez, Hui Yan, Gangadhara R Sareddy, Zhenming Xu, Brij B Singh, Philip T Valente, Yidong Chen, Zhao Lai, Manjeet Rao, Edward R Kost, Tyler Curiel, Rajeshwar R Tekmal, Hareesh B Nair, Ratna K Vadlamudi
Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis. NPJ precision oncology 8 (1) (2024)
Behnam Ebrahimi, Suryavathi Viswanadhapalli, Uday P Pratap, Gopalam Rahul, Xue Yang, Prabhakar Pitta Venkata, Viktor Drel, Bindu Santhamma, Swapna Konda, Xiaonan Li, Alondra Lee Rodriguez Sanchez, Hui Yan, Gangadhara R Sareddy, Zhenming Xu, Brij B Singh, Philip T Valente, Yidong Chen, Zhao Lai, Manjeet Rao, Edward R Kost, Tyler Curiel, Rajeshwar R Tekmal, Hareesh B Nair, Ratna K Vadlamudi
Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis. NPJ precision oncology 8 (1) (2024)
Behnam Ebrahimi, Suryavathi Viswanadhapalli, Uday P Pratap, Gopalam Rahul, Xue Yang, Prabhakar Pitta Venkata, Viktor Drel, Bindu Santhamma, Swapna Konda, Xiaonan Li, Alondra Lee Rodriguez Sanchez, Hui Yan, Gangadhara R Sareddy, Zhenming Xu, Brij B Singh, Philip T Valente, Yidong Chen, Zhao Lai, Manjeet Rao, Edward R Kost, Tyler Curiel, Rajeshwar R Tekmal, Hareesh B Nair, Ratna K Vadlamudi
Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis. NPJ precision oncology 8 (1) (2024)
Uday P Pratap, Michael Tidwell, Henriette U Balinda, Nicholas A Clanton, Xue Yang, Suryavathi Viswanadhapalli, Gangadhara R Sareddy, Dong Liang, Huan Xie, Yidong Chen, Zhao Lai, Rajeshwar R Tekmal, Stanton F McHardy, Andrew J Brenner, Ratna K Vadlamudi
Preclinical development of brain permeable ERβ agonist for the treatment of glioblastoma. Molecular cancer therapeutics (2023)
Nicole Spencer, Alondra Lee Rodriguez Sanchez, Rahul Gopalam, Panneerdoss Subbarayalu, Daisy M Medina, Xue Yang, Paulina Ramirez, Lois Randolph, Emily Jean Aller, Bindu Santhamma, Manjeet K Rao, Rajeshwar Rao Tekmal, Hareesh B Nair, Edward R Kost, Ratna K Vadlamudi, Suryavathi Viswanadhapalli
The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling. International journal of molecular sciences 24 (24) (2023)
Nicole Spencer, Alondra Lee Rodriguez Sanchez, Rahul Gopalam, Panneerdoss Subbarayalu, Daisy M Medina, Xue Yang, Paulina Ramirez, Lois Randolph, Emily Jean Aller, Bindu Santhamma, Manjeet K Rao, Rajeshwar Rao Tekmal, Hareesh B Nair, Edward R Kost, Ratna K Vadlamudi, Suryavathi Viswanadhapalli
The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling. International journal of molecular sciences 24 (24) (2023)
Xue Yang, Ling He, Xiao Xiao, Lei Yan, Liye Shi, Zhen Ren, Haiyi Cai, Chun Fu
Effectiveness of TruScreen for detecting CIN2+ in women with ThinPrep cytologic test results indicating atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions. Future oncology (London, England) (2023)
Nicole Spencer, Alondra Lee Rodriguez Sanchez, Rahul Gopalam, Panneerdoss Subbarayalu, Daisy M Medina, Xue Yang, Paulina Ramirez, Lois Randolph, Emily Jean Aller, Bindu Santhamma, Manjeet K Rao, Rajeshwar Rao Tekmal, Hareesh B Nair, Edward R Kost, Ratna K Vadlamudi, Suryavathi Viswanadhapalli
The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling. International journal of molecular sciences 24 (24) (2023)
Nicole Spencer, Alondra Lee Rodriguez Sanchez, Rahul Gopalam, Panneerdoss Subbarayalu, Daisy M Medina, Xue Yang, Paulina Ramirez, Lois Randolph, Emily Jean Aller, Bindu Santhamma, Manjeet K Rao, Rajeshwar Rao Tekmal, Hareesh B Nair, Edward R Kost, Ratna K Vadlamudi, Suryavathi Viswanadhapalli
The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling. International journal of molecular sciences 24 (24) (2023)